Excessive CpG 1668 stimulation triggers IL-10 production by cDC that inhibits IFN-α responses by pDC (Q57339899)

5

0 references

author name string

Zoe Waibler

1

0 references

Martina Anzaghe

2

0 references

Abdo Konur

3

0 references

Shizuo Akira

European Journal of Immunology

4

0 references

language of work or name

English

0 references

publication date

November 2008

0 references

published in

0 references

volume

38

0 references

issue

11

0 references

page(s)

3127-3137

0 references

cites work

Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-alpha production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

CpG motifs in bacterial DNA and their immune effects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Therapeutics targeting the innate immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Effect of Suppressive DNA on CpG-Induced Immune Activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Reciprocal regulation of plasmacytoid dendritic cells and monocytes during viral infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

P2Y receptor signaling regulates phenotype and IFN-alpha secretion of human plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Activation of autoreactive B cells by CpG dsDNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Negative regulation of toll-like receptor-mediated immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

TLR9-Dependent Recognition of MCMV by IPC and DC Generates Coordinated Cytokine Responses that Activate Antiviral NK Cell Function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Nucleosome, the Main Autoantigen in Systemic Lupus Erythematosus, Induces Direct Dendritic Cell Activation via a MyD88-Independent Pathway: Consequences on Inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

CpG DNA: recognition by and activation of monocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Spontaneous Formation of Nucleic Acid-based Nanoparticles Is Responsible for High Interferon-α Induction by CpG-A in Plasmacytoid Dendritic Cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Recognition of cytosolic DNA activates an IRF3-dependent innate immune response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Recognition of single-stranded RNA viruses by Toll-like receptor 7

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Cell type-specific involvement of RIG-I in antiviral response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

New insights into the molecular mechanism of interleukin-10-mediated immunosuppression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Production of interleukin-10 by mouse glial cells in culture

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.200838184

1 reference

7 January 2021

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Immunity and counter-immunity during infection with the parapoxvirus orf virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

Vaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838184

7 January 2021